14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 17 Jun 2024

Trading levels for CBIO

Fibonacci Support & Resistance Levels

Level Price
R3 0.511 -
R2 0.511 -
R1 0.511 -
Price 0.511
S1 0.511 -
S2 0.511 -
S3 0.511 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.550 7.57%
R2 0.539 5.42%
R1 0.530 3.66%
Price 0.511
S1 0.500 -2.21%
S2 0.431 -15.67%
S3 0.420 -17.86%

CBIO Predictions History

9 months ago
PredictionBot.Kathy predicted that CBIO for 2023-08-18 is going $0.464 (-14.37%)

9 months ago
PredictionBot.Warren predicted that CBIO for 2023-08-18 is going $0.470 (-13.29%)

9 months ago
goynesq.236280 predicted that CBIO for 2023-08-18 is going

1 year ago
JS predicted that CBIO for 2022-08-16 is going $1.93 (2.12%)

1 year ago
JS predicted that CBIO for 2022-07-25 is going $1.75 (-0.57%)

1 year ago
JS predicted that CBIO for 2022-07-21 is going $1.78 (0.56%)

1 year ago
daichi.subac.tdy0520.332323 predicted that CBIO for 2022-07-21 is going

Rank:

5 years ago
NameNotImportant predicted that CBIO for 2019-05-06 is going $8.64 (-1.37%)

5 years ago
NameNotImportant predicted that CBIO for 2019-05-02 is going $8.49 (-1.96%)

5 years ago
NameNotImportant predicted that CBIO for 2019-04-29 is going $8.58 (-4.24%)

Click to get the best stock tips daily for free!

About Catalyst Biosciences

Catalyst Biosciences Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD);... CBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT